FDA Import Refusal 112-8344752-5/1/2 — Glaxo Phils. Inc

Glaxo Phils. Inc — FEI 3003649604

The FDA refused shipment 112-8344752-5/1/2 from Glaxo Phils. Inc (Philippines) on Jul 29, 2009. The refused product falls under Drugs and Biologics — ANTI-DIABETIC N.E.C.. Cited charges: 118,75 This firm has 5 or more other import refusals on record.

Refusal details

Date
Jul 29, 2009
Country
Philippines
Product Category
Drugs and Biologics
Product Code
61PDB99 ANTI-DIABETIC N.E.C.
Charges
118,75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.